Finance

Lists
000538:SHE
Yunnan Baiyao Group Co Ltd
CNÂ¥52,90
+0,47%
(+0,25) 1D
15 Okt., 15:04:48 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000538...
Open
CNÂ¥52,64
High
CNÂ¥53,20
Low
CNÂ¥52,24
Mkt. cap
92,76 mjd
Avg. vol.
7,28 m
Volume
13,59 m
Dividend
4,95%
Quarterly dividend
CNÂ¥0,66
Ex-dividend date
30 Apr. 2026
P/E ratio
18,08
52-wk high
CNÂ¥58,20
52-wk low
CNÂ¥46,29
EPS
CNÂ¥2,93
Shares outstanding
1,78 mjd
No. of employees
9 k
Open
CNÂ¥52,64
High
CNÂ¥53,20
Low
CNÂ¥52,24
Mkt. cap
92,76 mjd
Avg. vol.
7,28 m
Volume
13,59 m
Dividend
4,95%
Quarterly dividend
CNÂ¥0,66
Ex-dividend date
30 Apr. 2026
P/E ratio
18,08
52-wk high
CNÂ¥58,20
52-wk low
CNÂ¥46,29
EPS
CNÂ¥2,93
Shares outstanding
1,78 mjd
No. of employees
9 k
News stories
From web sources and news partners
Profile
Yunnan Baiyao Group Co., Ltd is a Chinese pharmaceutical company that develops and manufactures pharmaceutical products and the wholesale and retail of pharmaceutical products. The Government Pension Fund of Norway has excluded the company from investments since 21 December 2021, since the company "uses and sells body parts from pangolins which is a globally endangered species". As of 2024, state and individual investors hold 29% of the shares and private companies hold 35%. The three largest shareholders hold 58 per cent of the company's shares. Wikipedia
About Yunnan Baiyao Group Co Ltd
CEO-
Employees9,29 k
Founded1902
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
9,40 mjd
10,53 mjd
11,60 mjd
10,28 mjd
Cost of goods sold
6,70 mjd
7,85 mjd
8,05 mjd
7,28 mjd
Cost of revenue
6,70 mjd
7,85 mjd
8,05 mjd
7,28 mjd
Research and development expenses
79,10 m
115,55 m
76,79 m
112,78 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,39 mjd
2,37 mjd
1,28 mjd
1,50 mjd
Operating expense
1,33 mjd
2,67 mjd
1,44 mjd
1,64 mjd
Total operating expenses
8,03 mjd
10,52 mjd
9,48 mjd
8,92 mjd
Operating income
1,37 mjd
12,79 m
2,12 mjd
1,36 mjd
Other non operating income
-43,28 m
135,88 m
-17,44 m
37,87 m
EBT including unusual items
1,38 mjd
428,17 m
2,36 mjd
1,92 mjd
EBT excluding unusual items
1,47 mjd
233,79 m
2,35 mjd
1,74 mjd
Income tax expense
238,66 m
27,40 m
330,30 m
255,01 m
Effective tax rate
17,25%
6,40%
13,99%
13,27%
Other operating expenses
-18,86 m
129,96 m
6,54 m
116,66 m
Net income
1,14 mjd
376,37 m
2,04 mjd
1,66 mjd
Net profit margin
12,18%
3,57%
17,56%
16,18%
Earnings per share
0,61
0,18
1,10
0,87
Interest and investment income
136,98 m
107,27 m
253,40 m
367,65 m
Interest expense
-4,39 m
-8,83 m
-5,09 m
-5,15 m
Net interest expenses
132,58 m
98,43 m
248,31 m
362,50 m
Depreciation and amortization charges
-
-
-
-
EBITDA
1,42 mjd
70,91 m
2,18 mjd
1,43 mjd
Gain or loss from assets sale
2,26 m
-8,17 m
-
-3,05 k
AI content may include mistakes. Learn more
Google-programme